Kymera Therapeutics, Inc. (KYMR) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Feb 26, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Kymera Therapeutics, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Kymera Therapeutics, Inc.'s filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-16.36%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Kymera Therapeutics, Inc. actually do?
Answer:
Kymera Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral medicines that target disease-causing proteins through targeted protein degradation (TPD). The company leverages its TPD platform to create novel therapies for significant health problems, primarily in immunology, aiming to offer biologics-like activity with the convenience of oral administration. Kymera's pipeline includes programs targeting STAT6, IRF5, and IRAK4, with KT-621 currently in Phase 2b trials for atopic dermatitis and asthma. The company has strategic collaborations with Sanofi for IRAK4 and Gilead for CDK2 programs, advancing its goal to become a fully integrated biopharmaceutical company.
Question:
What are Kymera Therapeutics, Inc.'s revenue drivers?
Answer:
Revenue is primarily derived from collaboration agreements with partners such as Sanofi and Gilead, which include upfront payments, milestone payments, and potential royalties on future sales.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required